28.11.2024

Researchers at the University of Chicago and the University of California San Diego have developed a flexible bioelectronic patch that delivers mild electrical signals to bacteria on the skin. This device presents a noninvasive, drug-free method to reduce the harmful effects of bacterial infections, particularly those resistant to antibiotics.

Image: Flexible exletroceutical patch placed on an arm; Copyright: Saehyun Kim, the University of Chicago

A flexible electroceutical patch that delivers gentle electrical signals to bacteria at a specific skin pH level

Products and exhibitors related to this topic

Exhibitors and products related to this topic can be found in the database of MEDICA:

Key features of the patch include:

Targeted activation: The device activates only in acidic environments, akin to the pH of healthy skin, ensuring precision treatment.

Reduced virulence: Electrical stimulation lowers harmful bacterial gene activity and prevents biofilm formation.

Localized therapy: By focusing treatment on specific areas, the patch minimizes side effects associated with systemic antibiotics.

A drug-free alternative for infection control

The patch’s electrical signals interact with bacteria like Staphylococcus epidermidis, a common cause of hospital-acquired infections. This interaction temporarily alters bacterial behavior, reducing colonization and the risk of biofilm-related complications. In preclinical tests on pig skin, the patch achieved a nearly tenfold reduction in bacterial growth, showcasing its effectiveness in real-world conditions.

Advancing bioelectronic medicine

The wearable patch, designed by the team led by Bozhi Tian at the University of Chicago, is soft, flexible, and compatible with skin conditions. Its ability to provide localized, drug-free therapy has significant implications for managing infections in patients with chronic wounds or medical implants. This technology opens the door to personalized, effective treatment options for infections that are difficult to manage with conventional antibiotics.

Future clinical applications

The research team is optimistic about the patch’s clinical potential. While currently in preclinical testing, the device holds promise for use in hospitals and outpatient care, especially for patients vulnerable to antibiotic-resistant infections. Its ability to reduce reliance on antibiotics aligns with global efforts to combat drug resistance.

Healthcare professionals are encouraged to monitor developments in bioelectronic medicine and consider the role such devices could play in improving infection control strategies. With ongoing research and advancements, this patch could represent a significant shift in how bacterial infections are managed.

MEDICA-tradefair.com; Source: University of Chicago

More about the University of Chicago at: www.uchicago.edu